The Venture Codex Logo

The Venture Codex

The CareVoice

100 Cyberport Rd, Hong Kong, Central and Western, China

Overview

The CareVoice is an embedded health company that develops an operating system (CareVoiceOS) and integrations to help insurers deliver digital health, fitness and wellness services. Started in Shanghai a decade ago, the company now has a footprint across 15 countries and operates with a team of around 40 employees. Its platform can make a first version live in as little as three months, and it powers products such as MetLife’s 360Health app with features including face-scanning illness detection and access to nearby checkup centers, plus prevention across physical, mental and cognitive wellness. The company reached cash-flow neutral from Q3 2022, doubled its revenues in 2023, and is headed toward revenues of about $10 million this year from a mix of recurring licensing payments and one-off implementation fees. The CareVoice plans to use the new funding to expand partnerships with insurers across Asia, Europe, the Middle East, Africa and the Americas and to invest in the next generation of CareVoiceOS. The startup positions itself as a faster, managed alternative to custom IT/consulting builds that can take years and cost several million dollars. The CareVoice offers CareVoiceOS, a plug-and-play, API-based healthcare operating system that lets insurers orchestrate health ecosystems and deploy bespoke customer journeys across multiple front-end channels. The platform (version 2.0) enables insurers to combine health services with insurance products under their own brand and to engage customers on any channel. The company has been expanding partnerships with major insurers including Generali, Cigna and Prudential Financial, and plans to roll out in 10 markets across Asia, Europe and Latin America within 6–9 months. CareVoice reports that revenue tripled over the prior 12 months and that it achieved positive EBITDA in Q1 2021. Operating scale includes 4 million serviceable members and 200,000 yearly paid members, with paid membership growing 400% in the past six months. Teams are based in Hong Kong, Shanghai, Singapore and Paris as the company accelerates international expansion. Founded in 2014, The CareVoice began as an app for patient reviews before shifting to a SaaS flagship product that makes healthcare and insurance products more accessible on mobile. Its core offering is an end-to-end platform—CareVoiceOS—that aims to integrate with insurers' existing systems rather than only serving as a sales tool. The company is used by 15 insurance providers in China and Hong Kong, including Ping An and AXA. It has launched StartupCare to let startups provide health benefits to founders and employees and is developing 10 new insurance products tailored to segmented consumer groups with health-insurance partners. The CareVoice is focused on improving enrollment, customer experience and claims processing. It plans to grow its business in Hong Kong and expand into other Asian markets. The CareVoice is a Shanghai-based healthtech platform that helps consumers find health and wellness providers and access insurance benefits. Operational since 2014, it was founded by Sebastien Gaudin and later joined by cofounders Jan Velich and Neil Liang after a pivot into health insurtech. The company said it enables customers to take advantage of insurance benefits and improve health through transparent, personalized services. Recent commercial traction includes customers such as AXA, Ping An and Chubb and an onboarding rate for newly-insured members that increased tenfold to over 50%. The CareVoice raised roughly $2 million in early growth capital to fund its insurance business lines and accelerate technology development. It plans to use the financing to consolidate its leadership in China’s major cities and to expand into Southeast Asia.

Total raised
$22M
Funding rounds
4
Latest round
Series B
Latest activity
Mar 2024

Industries

  • Apps
  • Health Care
  • Health Insurance
  • InsurTech
Visit website

Recent funding

  1. Series B

    Mar 2024

    $10M

  2. Series A

    Aug 2019

    $10M

  3. Equity

    Jan 2018

    $2M

Team